Breath biomarkers of lung cancer and other diseases

A. Amann (Innsbruck, Austria)

Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease
Session: Advances on breath monitoring of inflammatory airway disease
Session type: Hot topics
Number: 3613
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Amann (Innsbruck, Austria). Breath biomarkers of lung cancer and other diseases. Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improvements in lung cancer surgery
Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results
Year: 2011

Biomarkers for lung cancer screening
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011


Lung cancer
Source: Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
Year: 2010


Genome-wide approaches to lung cancer
Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease
Year: 2011


IPF and lung cancer: what are the links?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010

Indolent lung cancers
Source: Annual Congress 2011 - Slow-growing lung cancer
Year: 2011


Electronic nose distinguishes lung cancer from smoking and nonsmoking controls
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010

Breath biomarkers for lung cancer detection: ready for use by the pulmonologist?
Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer
Year: 2012



Resistance training in radically treated lung cancer patients
Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation
Year: 2010

Molecular signatures of exposure and subtype in lung cancer tissue from uranium miners
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


Advances in interstitial lung diseases
Source: Annual Congress 2011 - Clinical Year in Review I
Year: 2011


Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010

Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Advances in lung transplantation
Source: Annual Congress 2011 - Clinical Year in Review I
Year: 2011


Biomarkers in asthma and COPD
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011


Interstitial lung disease
Source: Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
Year: 2010